- $2.28m
- -$12.65m
- $34.76m
Annual balance sheet for C3is, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | 20-F | 20-F | 6-K |
| Standards: | USG | USG | USG | — |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | — | 9.06 | 12.6 | 14.9 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.822 | 10.4 | 2.82 | 4.26 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 1.02 | 20.3 | 16.3 | 20.8 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 38.8 | 75.2 | 84.1 | 77.6 |
| Total Assets | 39.9 | 95.5 | 100 | 98.5 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.965 | 39.9 | 18.7 | 3.36 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.965 | 39.9 | 29.1 | 3.39 |
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 38.9 | 55.5 | 71.4 | 95.1 |
| Total Liabilities & Shareholders' Equity | 39.9 | 95.5 | 100 | 98.5 |
| Total Common Shares Outstanding |